gefitinib has been researched along with Adrenal Insufficiency in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kagohashi, K; Ohara, G; Okauchi, S; Sasatani, Y; Satoh, H | 1 |
1 other study(ies) available for gefitinib and Adrenal Insufficiency
Article | Year |
---|---|
Prolonged response after the discontinuation of nivolumab after resistance to gefitinib.
Topics: Adenocarcinoma of Lung; Adrenal Insufficiency; Aged; Antineoplastic Agents, Immunological; Central Nervous System Neoplasms; Gefitinib; Genes, erbB-1; Humans; Lung Neoplasms; Male; Mutation; Nivolumab; Protein Kinase Inhibitors; Treatment Outcome; Withholding Treatment | 2019 |